We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 76

New Hampshire Bill Would Requires Ingredient Labels and Ban Certain Ingredients for E-Liquids
  • Troutman Sanders LLP
  • USA
  • January 5 2018

A bill was introduced in the New Hampshire legislature on January 3, 2018 regarding the regulation of e-liquids. The bill, NH18-H.1812, specifically

MDL court rejects primary jurisdiction defense in hand soap antibacterial lawsuits
  • Shook Hardy & Bacon LLP
  • USA
  • March 28 2013

A federal multidistrict litigation (MDL) court in New Hampshire has denied the motion to dismiss filed by the defendant in consolidated class actions

U.S. Supreme Court addresses “failure to warn” negligence claims in Rx warning labels
  • Husch Blackwell LLP
  • USA
  • March 28 2013

New Hampshire law applies a hybrid design-defect standard that imposes liability for harm caused by a drug product if the drug product, in light of

New Hampshire State Senate hearing on prohibition of certain physician relationships with medical device companies
  • Reed Smith LLP
  • USA
  • May 3 2012

The New Hampshire State Senate held a hearing on April 19, 2012 regarding HB 1725, a new measure that would prohibit all health care practitioners from prescribing or referring any U.S. Food and Drug Administration class II or class III implantable medical device if the practitioner stands to “profit indirectly or directly from the sale of the medical device by any supplier in which the health care practitioner has a direct or indirect ownership interest.”

New Hampshire quietly considers prohibition of physician relationships with medical device companies
  • Reed Smith LLP
  • USA
  • April 17 2012

On March 29, 2012, the New Hampshire House of Representatives recommended for passage HB 1725.